← The Wire
RLMDNasdaq
RELMADA THERAPEUTICS, INC.
Pharmaceutical Preparations · NV · CIK 1553643
Relmada Therapeutics develops novel drug formulations for bladder cancer and neurological disorders
$698M
Market cap
$6.98
Last close
+4.3%
1D
+1.3%
5D
2.3M
Volume
Price · last 39 sessions-5.8%
May 4L $5.72 · H $7.86Jun 29
272
Total filings
May 28, 2026
Last filing
12/31
Fiscal year end
8-KBylaw Amendment · Shareholder VoteMay 28, 20268-KResults of Operations · Reg FD DisclosureMay 12, 20268-KResults of Operations · Reg FD DisclosureMar 20, 20268-KMaterial Agreement · Equity IssuanceMar 9, 20268-KExecutive ChangeDec 15, 20258-KResults of Operations · Reg FD DisclosureNov 13, 20258-KMaterial Agreement · Reg FD DisclosureNov 5, 20258-KReg FD Disclosure · Company UpdateNov 4, 20258-KReg FD DisclosureSep 17, 20258-KCompany UpdateSep 16, 20258-KReg FD DisclosureSep 10, 20258-KReg FD DisclosureSep 2, 20258-KResults of Operations · Reg FD DisclosureAug 7, 20258-KDelisting NoticeJul 23, 20258-KAgreement TerminatedJul 10, 20258-KReg FD DisclosureJun 18, 20258-KShareholder VoteMay 27, 20258-KAuditor ChangeMay 12, 20258-KReg FD Disclosure · Company UpdateApr 28, 20258-KResults of OperationsMar 27, 20258-KMaterial Agreement · Equity IssuanceMar 26, 20258-KMaterial Agreement · Reg FD DisclosureFeb 6, 20258-KDelisting NoticeJan 27, 20258-KExecutive ChangeJan 6, 20258-KReg FD DisclosureDec 9, 20248-KReg FD DisclosureDec 4, 20248-KShareholder VoteMay 30, 20248-KResults of OperationsMar 19, 20248-KExecutive ChangeJan 11, 20248-KReg FD DisclosureJan 4, 20248-KExecutive ChangeJan 3, 20248-KResults of OperationsNov 8, 20238-KReg FD DisclosureOct 11, 20238-KCompany UpdateOct 10, 20238-KCompany UpdateOct 4, 20238-KReg FD DisclosureSep 20, 20238-KExecutive ChangeSep 6, 20238-KCompany UpdateAug 10, 20238-KResults of OperationsAug 8, 20238-KExecutive Change · Shareholder VoteMay 25, 20238-KCompany UpdateMay 15, 20238-KResults of OperationsMay 11, 20238-KCompany UpdateApr 19, 20238-KResults of OperationsMar 23, 20238-KReg FD DisclosureMar 13, 20238-KExecutive Change · Material AgreementJan 17, 20238-KReg FD Disclosure · Company UpdateJan 9, 20238-KMaterial Agreement · Company UpdateJan 5, 20238-KMaterial AgreementDec 28, 20228-KReg FD Disclosure · Company UpdateDec 7, 20228-KCompany UpdateNov 14, 20228-KResults of Operations · Reg FD DisclosureNov 10, 20228-KReg FD Disclosure · Company UpdateOct 13, 20228-KMaterial Agreement · Equity IssuanceSep 22, 20228-KCompany UpdateSep 20, 20228-KExecutive Change · Shareholder VoteJun 1, 20228-KResults of Operations · Company UpdateMay 5, 20228-KResults of OperationsMar 23, 20228-KCompany UpdateMar 7, 20228-KReg FD Disclosure · Company UpdateFeb 23, 20228-KReg FD DisclosureDec 22, 20218-KCompany UpdateDec 20, 20218-KMaterial AgreementDec 13, 20218-KCompany UpdateDec 7, 20218-KCompany UpdateNov 23, 20218-KCompany UpdateNov 15, 20218-KCompany UpdateOct 7, 20218-KMaterial AgreementJul 20, 20218-KExecutive Change · Shareholder VoteMay 20, 20218-KResults of OperationsMar 23, 20218-KReg FD DisclosureMar 15, 20218-KReg FD DisclosureMar 15, 20218-KCompany UpdateJan 7, 20218-KExecutive ChangeJan 5, 20218-KCompany UpdateDec 14, 20208-KCompany UpdateDec 8, 20208-KCompany UpdateNov 16, 20208-KCompany UpdateOct 27, 20208-KCompany UpdateJun 3, 20208-KExecutive Change · Material AgreementMar 12, 2020
Insider Activity
◆ Cluster Buy · 4 insidersIn the 90 days to Dec 15, 2025: 4 insiders bought $2.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 15, 2025 | Traversa SergioChief Executive Officer | Buy | 27,500 | $4.12 | $113K |
| Dec 15, 2025 | Shenouda MagedChief Financial Officer | Buy | 11,665 | $4.12 | $48K |
| Nov 5, 2025 | Shenouda MagedChief Financial Officer | Buy | 500,000 | $2.20 | $1.1M |
| Nov 5, 2025 | Traversa SergioChief Executive Officer | Buy | 272,500 | $2.20 | $600K |
| Nov 5, 2025 | Ence ChuckCAO and COO | Buy | 136,000 | $2.20 | $299K |
| Nov 5, 2025 | Kelly Paul EdwardChief Operating Officer | Buy | 90,000 | $2.20 | $198K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance